According to Meridian Bioscience's latest financial reports and stock price the company's current number of shares outstanding is 43,749,000. At the end of 2022 the company had 43,749,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2022 | 43.74 M | 0.71% |
2021 | 43.43 M | 0.79% |
2020 | 43.09 M | 0.72% |
2019 | 42.78 M | 0.81% |
2018 | 42.44 M | 0.43% |
2017 | 42.26 M | 0.25% |
2016 | 42.15 M | 0.51% |
2015 | 41.94 M | 0.82% |
2014 | 41.6 M | 0.48% |
2013 | 41.4 M | 0.63% |
2012 | 41.14 M | 0.2% |
2011 | 41.06 M | 1.11% |
2010 | 40.61 M | 0.29% |
2009 | 40.49 M | 0.44% |
2008 | 40.31 M | 1.02% |
2007 | 39.91 M | 52.39% |
2006 | 26.18 M | 0.65% |
2005 | 26.01 M | 72.9% |
2004 | 15.04 M | 1.86% |
2003 | 14.77 M | 0.95% |
2002 | 14.63 M | 0.25% |
2001 | 14.59 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 387,000,000 | 784.59% | ๐บ๐ธ USA |
Becton Dickinson BDX | 290,113,000 | 563.13% | ๐บ๐ธ USA |
Hologic HOLX | 238,627,000 | 445.45% | ๐บ๐ธ USA |
QuidelOrtho QDEL | 66,900,000 | 52.92% | ๐บ๐ธ USA |